S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
BellRing Brands gets pumped on the Ozempic weight-loss trend
Get ready for Christmas shopping-sprees with these 2 winners

American Well Stock Price, News & Analysis (NYSE:AMWL)

$1.24
+0.04 (+3.35%)
(As of 11/27/2023 ET)
Compare
Today's Range
$1.16
$1.27
50-Day Range
$0.93
$1.42
52-Week Range
$0.93
$4.28
Volume
1.25 million shs
Average Volume
2.20 million shs
Market Capitalization
$355.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.71

American Well MarketRank™ Stock Analysis

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
200.2% Upside
$3.71 Price Target
Short Interest
Healthy
2.99% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$325,230 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.84) to ($0.67) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

451st out of 935 stocks

Business Services, Not Elsewhere Classified Industry

59th out of 89 stocks


AMWL stock logo

About American Well Stock (NYSE:AMWL)

American Well Corporation operates digital care delivery enablement platform in the United States and internationally. Its platform connects and enables providers, insurers, patients, and innovators to deliver access for quality care. The company's products offer urgent care; scheduled visits; acute behavioral health; telestroke; comprehensive behavioral health; ED triage; pediatrics; end-stage renal disease and dialysis; and retail health, school health, and home settings. Its application offers telehealth urgent care; primary care; chronic care; digital therapy; teledermatology; manage Medicaid; behavior health; online nutrition counselling; sleep; women's health; employee assistance program therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, hospital TV kits, and telehealth tablets. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

AMWL Stock Price History

AMWL Stock News Headlines

Important info on NVDA trade
Today, I’m pulling back the curtain on my all-new Everyday Income project. A way for everyday folks to target a couple hundred bucks or more every single day the markets are open… Without breaking a sweat!
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Q3 2023 American Well Corp Earnings Call
American Well (AMWL) Q3 2023 Earnings Call Transcript
Amwell Announces Results for Third Quarter 2023
Why American Well Stock Blasted Higher on Friday Morning
Amwell® to Participate in Key HLTH 2023 Engagements
See More Headlines
Receive AMWL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Well and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2023
Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/28/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
1,035
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.71
High Stock Price Target
$5.00
Low Stock Price Target
$1.75
Potential Upside/Downside
+200.2%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Net Income
$-270,430,000.00
Net Margins
-257.20%
Pretax Margin
-255.92%

Debt

Sales & Book Value

Annual Sales
$277.19 million
Book Value
$3.91 per share

Miscellaneous

Free Float
250,358,000
Market Cap
$355.15 million
Optionable
Not Optionable
Beta
0.90
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives















AMWL Stock Analysis - Frequently Asked Questions

Should I buy or sell American Well stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for American Well in the last year. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMWL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMWL, but not buy additional shares or sell existing shares.
View AMWL analyst ratings
or view top-rated stocks.

What is American Well's stock price target for 2024?

7 brokerages have issued 1-year price objectives for American Well's shares. Their AMWL share price targets range from $1.75 to $5.00. On average, they expect the company's share price to reach $3.71 in the next year. This suggests a possible upside of 200.2% from the stock's current price.
View analysts price targets for AMWL
or view top-rated stocks among Wall Street analysts.

How have AMWL shares performed in 2023?

American Well's stock was trading at $2.83 at the beginning of 2023. Since then, AMWL shares have decreased by 56.4% and is now trading at $1.2350.
View the best growth stocks for 2023 here
.

Are investors shorting American Well?

American Well saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 8,600,000 shares, a drop of 5.5% from the October 15th total of 9,100,000 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is presently 5.1 days.
View American Well's Short Interest
.

When is American Well's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our AMWL earnings forecast
.

How were American Well's earnings last quarter?

American Well Co. (NYSE:AMWL) released its quarterly earnings results on Wednesday, November, 1st. The company reported ($0.20) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.20). The company earned $61.92 million during the quarter, compared to analyst estimates of $62.89 million. American Well had a negative net margin of 257.20% and a negative trailing twelve-month return on equity of 33.76%.

What ETFs hold American Well's stock?

ETFs with the largest weight of American Well (NYSE:AMWL) stock in their portfolio include Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

What other stocks do shareholders of American Well own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Well investors own include PayPal (PYPL), NVIDIA (NVDA), Shopify (SHOP), Tesla (TSLA), Twilio (TWLO), Salesforce (CRM), Livongo Health (LVGO), Skyworks Solutions (SWKS), Slack Technologies (WORK) and Adobe (ADBE).

When did American Well IPO?

(AMWL) raised $525 million in an initial public offering on Thursday, September 17th 2020. The company issued 35,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, Goldman Sachs, PIper Sandler, UBS Investment Bank, Credit Suisse, Cowen and Berenberg acted as the underwriters for the IPO.

Who are American Well's major shareholders?

American Well's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Senvest Management LLC (8.01%), Northern Trust Corp (0.80%), Charles Schwab Investment Management Inc. (0.69%), Rock Point Advisors LLC (0.66%), UBS Group AG (0.38%) and GSA Capital Partners LLP (0.25%). Insiders that own company stock include Amber Howe, Bradford Gay, Brendan P Ogrady, Deborah C Jackson, Deval L Patrick, Ido Schoenberg, Jason Medeiros, Keith Anderson, Kurt Knight, Mary Modahl, Paul Francis Mcneice, Peter L Slavin, Phyllis Gotlib, Robert Shepardson, Roy Schoenberg, Serkan Kutan, Stephen J Schlegel and Vukasin Paunovich.
View institutional ownership trends
.

How do I buy shares of American Well?

Shares of AMWL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:AMWL) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -